Efficacy and tolerability of a 12-week combination chemotherapy followed by lomustine consolidation treatment in canine B- and T-cell lymphoma

BACKGROUND: High-grade lymphoma in dogs is a chemotherapy-responsive neoplasia with remission rates exceeding 80% under combination chemotherapy protocols. Usually these protocols are intensive and 24 + weeks. The objective of the present study was to investigate if a shorter protocol combined with...

Descripción completa

Detalles Bibliográficos
Autores principales: Limmer, Stefanie, Nerschbach, Verena, Eberle, Nina, Teske, Erik, Simon Betz, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743771/
https://www.ncbi.nlm.nih.gov/pubmed/36503518
http://dx.doi.org/10.1186/s13028-022-00660-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743771/
https://www.ncbi.nlm.nih.gov/pubmed/36503518
http://dx.doi.org/10.1186/s13028-022-00660-z

Ejemplares similares